已发表论文

两性霉素 B 可降低伏立康唑血清水平:一病例报告及文献综述

 

Authors Hu Z, Zhou H

Received 16 May 2022

Accepted for publication 5 September 2022

Published 12 September 2022 Volume 2022:15 Pages 5397—5400

DOI https://doi.org/10.2147/IDR.S374853

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Suresh Antony

Background: Combination therapy with amphotericin B (AmB) and Voriconazole are sometimes used due to reducing AmB-related adverse reactions and improving outcomes. However, there was no report whether AmB would affect the serum level of Voriconazole.
Case Presentation: A patient was in presumption of invasive fungal infection. Voriconazole and amphotericin B was combined for administration. The results showed that serum levels of Voriconazole were dramatically reduced when combined AmB, whereas went up when receiving Voriconazole alone.
Conclusion: AmB might decrease the level of Voriconazole. Such a combination of AmB and Voriconazole cannot be considered appropriate until more data are available.
Keywords: amphotericin B, voriconazole, fungal infection, drug interaction